trio pharm ltd
trio pharm ltd Company Information
Company Number
14520072
Next Accounts
Sep 2025
Shareholders
aliasgher sachoo
m ramani limited
View AllGroup Structure
View All
Industry
Other human health activities
Registered Address
2e graham road, wealdstone, harrow, HA3 5RF
Website
-trio pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of TRIO PHARM LTD at £248.6k based on a Turnover of £627.7k and 0.4x industry multiple (adjusted for size and gross margin).
trio pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of TRIO PHARM LTD at £63.1k based on an EBITDA of £20.7k and a 3.05x industry multiple (adjusted for size and gross margin).
trio pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of TRIO PHARM LTD at £36.4k based on Net Assets of £15.5k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Trio Pharm Ltd Overview
Trio Pharm Ltd is a live company located in harrow, HA3 5RF with a Companies House number of 14520072. It operates in the other human health activities sector, SIC Code 86900. Founded in December 2022, it's largest shareholder is aliasgher sachoo with a 37.5% stake. Trio Pharm Ltd is a startup, small sized company, Pomanda has estimated its turnover at £627.7k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Trio Pharm Ltd Health Check
Pomanda's financial health check has awarded Trio Pharm Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
6 Weak
Size
annual sales of £627.7k, make it smaller than the average company (£798.8k)
- Trio Pharm Ltd
£798.8k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Trio Pharm Ltd
- - Industry AVG
Production
with a gross margin of 21%, this company has a higher cost of product (36.6%)
- Trio Pharm Ltd
36.6% - Industry AVG
Profitability
an operating margin of 3.3% make it less profitable than the average company (5.5%)
- Trio Pharm Ltd
5.5% - Industry AVG
Employees
with 6 employees, this is below the industry average (19)
6 - Trio Pharm Ltd
19 - Industry AVG
Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- Trio Pharm Ltd
£27k - Industry AVG
Efficiency
resulting in sales per employee of £104.6k, this is more efficient (£51.5k)
- Trio Pharm Ltd
£51.5k - Industry AVG
Debtor Days
it gets paid by customers after 106 days, this is later than average (23 days)
- Trio Pharm Ltd
23 days - Industry AVG
Creditor Days
its suppliers are paid after 78 days, this is slower than average (17 days)
- Trio Pharm Ltd
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Trio Pharm Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Trio Pharm Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 97.7%, this is a higher level of debt than the average (27.9%)
97.7% - Trio Pharm Ltd
27.9% - Industry AVG
TRIO PHARM LTD financials
Trio Pharm Ltd's latest turnover from December 2023 is estimated at £627.7 thousand and the company has net assets of £15.5 thousand. According to their latest financial statements, Trio Pharm Ltd has 6 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | |
|---|---|
| Turnover | |
| Other Income Or Grants | |
| Cost Of Sales | |
| Gross Profit | |
| Admin Expenses | |
| Operating Profit | |
| Interest Payable | |
| Interest Receivable | |
| Pre-Tax Profit | |
| Tax | |
| Profit After Tax | |
| Dividends Paid | |
| Retained Profit | |
| Employee Costs | |
| Number Of Employees | 6 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | |
|---|---|
| Tangible Assets | 502,403 |
| Intangible Assets | |
| Investments & Other | |
| Debtors (Due After 1 year) | |
| Total Fixed Assets | 502,403 |
| Stock & work in progress | |
| Trade Debtors | 183,909 |
| Group Debtors | |
| Misc Debtors | |
| Cash | |
| misc current assets | |
| total current assets | 183,909 |
| total assets | 686,312 |
| Bank overdraft | |
| Bank loan | |
| Trade Creditors | 106,090 |
| Group/Directors Accounts | |
| other short term finances | |
| hp & lease commitments | |
| other current liabilities | |
| total current liabilities | 106,090 |
| loans | |
| hp & lease commitments | |
| Accruals and Deferred Income | |
| other liabilities | 564,722 |
| provisions | |
| total long term liabilities | 564,722 |
| total liabilities | 670,812 |
| net assets | 15,500 |
| total shareholders funds | 15,500 |
| Dec 2023 | |
|---|---|
| Operating Activities | |
| Operating Profit | |
| Depreciation | |
| Amortisation | |
| Tax | |
| Stock | |
| Debtors | 183,909 |
| Creditors | 106,090 |
| Accruals and Deferred Income | |
| Deferred Taxes & Provisions | |
| Cash flow from operations | |
| Investing Activities | |
| capital expenditure | |
| Change in Investments | |
| cash flow from investments | |
| Financing Activities | |
| Bank loans | |
| Group/Directors Accounts | |
| Other Short Term Loans | |
| Long term loans | |
| Hire Purchase and Lease Commitments | |
| other long term liabilities | 564,722 |
| share issue | |
| interest | |
| cash flow from financing | |
| cash and cash equivalents | |
| cash | |
| overdraft | |
| change in cash |
trio pharm ltd Credit Report and Business Information
Trio Pharm Ltd Competitor Analysis
Perform a competitor analysis for trio pharm ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in HA3 area or any other competitors across 12 key performance metrics.
trio pharm ltd Ownership
TRIO PHARM LTD group structure
Trio Pharm Ltd has no subsidiary companies.
Ultimate parent company
TRIO PHARM LTD
14520072
trio pharm ltd directors
Trio Pharm Ltd currently has 3 directors. The longest serving directors include Mr Sarfaraz Juma (Dec 2022) and Mr Meisamali Ramani (Dec 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Sarfaraz Juma | England | 37 years | Dec 2022 | - | Director |
| Mr Meisamali Ramani | United Kingdom | 35 years | Dec 2022 | - | Director |
| Mr Aliasgher Sachoo | United Kingdom | 34 years | Dec 2022 | - | Director |
P&L
December 2023turnover
627.7k
0%
operating profit
20.7k
0%
gross margin
21.1%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
15.5k
0%
total assets
686.3k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
trio pharm ltd company details
company number
14520072
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
December 2022
age
3
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
2e graham road, wealdstone, harrow, HA3 5RF
Bank
-
Legal Advisor
-
trio pharm ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to trio pharm ltd. Currently there are 2 open charges and 0 have been satisfied in the past.
trio pharm ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TRIO PHARM LTD. This can take several minutes, an email will notify you when this has completed.
trio pharm ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
